← All trials
NCT04924491
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 10, 2020
- Primary completion
- Dec 31, 2025
- Completion date
- Dec 31, 2025
- First posted
- Jun 14, 2021
- Last posted
- Jun 14, 2021
- Enrollment
- 10
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hospital General Universitario Gregorio MarañonLead sponsor
- Hospital General Universitario Gregorio MarañonSponsor investigator
- Hospital General Universitario Gregorio MarañonOverall official - principal investigator
- Universidad Carlos III MadridCollaborator
- Fundación Familia AlonsoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.